Previous close | 20.34 |
Open | 20.59 |
Bid | 21.27 x 100 |
Ask | 21.45 x 400 |
Day's range | 20.26 - 22.00 |
52-week range | 19.65 - 79.65 |
Volume | |
Avg. volume | 630,540 |
Market cap | 1.151B |
Beta (5Y monthly) | 0.24 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
DUBLIN, Ireland, May 01, 2024--Prothena announced that it will report first quarter 2024 financial results on Wednesday, May 8, 2024, after the close of the U.S. financial markets.
DUBLIN, April 15, 2024--Prothena today announced a publication related to the mechanism of action, pharmacological characteristics, and clinical utility of birtamimab.
DUBLIN, March 05, 2024--Prothena today announced that members of its senior management team will participate in two upcoming investor conferences in March.